Ostrowski et al. 26 examined plasma syndecan-1 in 571 patients with ST-myocardial infarction treated by percutaneous coronary intervention and a high syndecan-1 level was independently correlated to 30-day cardiovascular- and all-cause mortality in two univariate analyses (p = 0.012 and p = 0.002). Here, SDC1 is linked to myocardial infarction.